1-5 of 5
Andrew Cooper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

324-OR: Global Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: Results from DISCOVER

SUZANNE V. ARNOLD, FENGMING TANG, ANDREW COOPER, HUNGTA CHEN, MARILIA B. GOMES, WOLFGANG RATHMANN, IICHIRO SHIMOMURA, JITEN VORA, HIROTAKA WATADA, KAMLESH KHUNTI, MIKHAIL N. KOSIBOROD
Journal: Diabetes
Diabetes 2021;70(Supplement_1):324-OR
https://doi.org/10.2337/db21-324-OR
Published: 01 June 2021
View article titled, 324-OR: Global Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: Results from DISCOVER
Meeting Abstracts

40-OR: Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER

ANTONIO NICOLUCCI, HUNGTA CHEN, ANDREW COOPER, MARILIA B. GOMES, LINONG JI, KAMLESH KHUNTI, MIKHAIL N. KOSIBOROD, PAUL LEIGH, LARISA RAMIREZ, MARINA V. SHESTAKOVA, IICHIRO SHIMOMURA, AFRAH SIDDIQUI, FENGMING TANG, JITEN VORA, HIROTAKA WATADA, SUZANNE V. ARNOLD
Journal: Diabetes
Diabetes 2020;69(Supplement_1):40-OR
https://doi.org/10.2337/db20-40-OR
Published: 01 June 2020
View article titled, 40-OR: Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER
Meeting Abstracts

1590-P: Effects of Second-Line Metformin Combination Therapies on Weight, HbA1c, and Risk of Hypoglycemia over 3 Years: The DISCOVER Study

KAMLESH KHUNTI, BERNARD CHARBONNEL, ANDREW COOPER, MARILIA B. GOMES, LINONG JI, PAUL LEIGH, ANTONIO NICOLUCCI, WOLFGANG RATHMANN, MARINA V. SHESTAKOVA, AFRAH SIDDIQUI, FENGMING TANG, HIROTAKA WATADA, HUNGTA CHEN
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1590-P
https://doi.org/10.2337/db20-1590-P
Published: 01 June 2020
View article titled, 1590-P: Effects of Second-Line Metformin Combination Therapies on Weight, HbA1c, and Risk of Hypoglycemia over 3 Years: The DISCOVER Study
Meeting Abstracts

1598-P: HbA1c <7.0% 6 Months after Initiation of Second-Line Therapy in Patients with Uncontrolled Type 2 Diabetes Is Associated with Good Glycemic Control at 3 Years: The DISCOVER Study

FABRICE BONNET, HUNGTA CHEN, ANDREW COOPER, MARILIA B. GOMES, LINONG JI, PAUL LEIGH, LARISA RAMIREZ GUTIERREZ, MARINA V. SHESTAKOVA, IICHIRO SHIMOMURA, AFRAH SIDDIQUI, FENGMING TANG, JITEN VORA, HIROTAKA WATADA, KAMLESH KHUNTI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1598-P
https://doi.org/10.2337/db20-1598-P
Published: 01 June 2020
View article titled, 1598-P: HbA1c &lt;7.0% 6 Months after Initiation of Second-Line Therapy in Patients with Uncontrolled Type 2 Diabetes Is Associated with Good Glycemic Control at 3 Years: The DISCOVER Study
Journal Articles

Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance : The Medical Research Council Ely Prospective Study 1990–2000

Nita G. Forouhi, Jian'an Luan, Andrew Cooper, Barbara J. Boucher, Nicholas J. Wareham
Journal: Diabetes
Diabetes 2008;57(10):2619–2625
https://doi.org/10.2337/db08-0593
Published: 01 October 2008
View article titled, Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance : <subtitle>The Medical Research Council Ely Prospective Study 1990–2000</subtitle>
Open the PDF for Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance : <subtitle>The Medical Research Council Ely Prospective Study 1990–2000</subtitle> in another window